Abstract
Coronavirus disease 2019 (COVID-19) caused by the virus SARS-CoV-2 was declared a pandemic by the World Health Organization (WHO) in March 2020. The clinical spectrum of COVID-19 can range from asymptomatic to severe symptoms and even death. Recent studies show that a growing number of patients with COVID-19 will experience prolonged symptoms (Post-Acute Sequalae of SARS-CoV-2), which now days known as “Long Covid”. A team of researchers from Italy reported that nearly 9 in 10 patients discharged were still experiencing at least one symptom 60 days after infection. Symptoms reported are fatigue, dyspnea, joint pain, chest pain, and other uncommon symptoms. Through ACE2 surface receptor, SARS-CoV-2 has been linked to cardiovascular events. As PASC symptoms vary widely, cardiovascular sequelae need to be considered through lifetime management. Therefore, this review aims to summarize an update of the long covid effect on Cardiovascular Disease (CVD), the impacts, and Post-Acute Sequalae of SARS-CoV-2 Infection (PASC) management.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
